Cargando…
Treatment of COVID-19 in a Patient With Maple Syrup Urine Disease
Maple syrup urine disease (MSUD) is an inborn error of metabolism caused by a defect in the branched-chain alpha-ketoacid dehydrogenase complex (BCKDC). This leads to the accumulation of the branched-chain amino acids (BCAAs) leucine, isoleucine, and valine, which can cause neurotoxicity. Patients w...
Autores principales: | Morton, Kara F, Goetz, Ryan L, Linscott, Kristin B, Van Wagoner, Nicholas J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126471/ https://www.ncbi.nlm.nih.gov/pubmed/35619835 http://dx.doi.org/10.7759/cureus.24368 |
Ejemplares similares
-
Identification of gene mutations in six Chinese patients with maple syrup urine disease
por: Li, Lulu, et al.
Publicado: (2023) -
Neuroradiological findings in maple syrup urine disease
por: Indiran, Venkatraman, et al.
Publicado: (2013) -
Intramyelinic edema in maple syrup urine disease
por: Cornelius, Leema Pauline, et al.
Publicado: (2014) -
Maple syrup urine disease: mechanisms and management
por: Blackburn, Patrick R, et al.
Publicado: (2017) -
New zebrafish model for maple syrup urine disease
Publicado: (2012)